TRAIL - Clinical trial • Breast Cancer Foundation NZ

We're here to help during Covid-19. Find out more here. 


Early Breast Cancer clinical trials for ER+

Updated: July 3, 2019

The purpose of this study is to determine if breast cancer genetic material (known as circulating tumour DNA (ctDNA) can be detected in the bloodstream. It is hoped that this research will demonstrate the utility of this circulating material as an early marker of residual or recurrent breast cancer activity after treatment

Who is it for?

You may be eligible for this study if you are aged 18 or over and have confirmed non-metastatic adenocarcinoma of the breast.

Study details

You will require a blood test every three months for two years from the time of registration to the main study. As part of this study, you will also need to complete questionnaires that ask about your feelings towards the regular blood tests and thoughts of cancer return. If the ctDNA levels are detected in your bloodstream during the two year period, you will be asked to return to have a CT and/or bone scan.

Full trial information


Austin Hospital, Melbourne
Peter MacCallum Cancer Centre, Melbourne


Peter MacCallum Cancer Centre: Professor Sarah-Jane Dawson

If you think you might be a candidate for this trial, use the contact details supplied, or talk to your doctor.

Want to access a trial that's not in your area? It's not always possible, but if you're interested, email us at

Similar clinical trials

For Early Breast Cancer

Are we out of date? If you have updated or new information about a trial, we’d be grateful if you’d share it with us – email your update to

Find clinical trials

Interested in a clinical trial?

Subscribe for updates & stay in the loop with new studies.